(Q51250976)

English

Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.

scientific article published on 12 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

chemoradiotherapy

0 references

3

object named as

Yoshinori Ito

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

author name string

Ken Kato

1

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Takako Eguchi Nakajima

2

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Chikatoshi Katada

4

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Hiromichi Ishiyama

5

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Shin-ya Tokunaga

6

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Masahiro Tanaka

7

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Shuichi Hironaka

8

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Takayuki Hashimoto

9

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Takashi Ura

10

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Takeshi Kodaira

11

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Ken-ichi Yoshimura

12

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

publication date

12 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

43

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

6

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

608-615

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Management of intraocular retinoblastoma and ocular prognosis

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

The prognostic impact of occult lymph node metastasis in cancer of the esophagus or esophago-gastric junction: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Late effects of treatment for Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Toxicity associated to radiotherapy treatment in lung cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYT048

21 January 2018

Identifiers

10.1093/JJCO/HYT048

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/23585687

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51250976&oldid=1756221430"